Literature DB >> 20623203

The relationship of plasma adiponectin with liver fibrosis in morbid obesity.

Teoman Dogru, Nuri Karadurmus, Guldem Kilciler, Serkan Tapan, Cemal Nuri Ercin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20623203     DOI： 10.1007/s11695-010-0195-y

Source DB:  PubMed          Journal:  Obes Surg        ISSN： 0960-8923            Impact factor:   4.129


× No keyword cloud information.
  7 in total

1.  Effect of antihypertensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome.

Authors:  Mahmut I Yilmaz; Alper Sonmez; Kayser Caglar; Turgay Celik; Müjdat Yenicesu; Tayfun Eyileten; Cengizhan Acikel; Yusuf Oguz; Izzet Yavuz; Abdulgaffar Vural
Journal:  Nephrology (Carlton)       Date:  2007-04       Impact factor: 2.506

2.  Valsartan increases circulating adiponectin levels without changing HOMA-IR in patients with type 2 diabetes mellitus and hypertension.

Authors:  J-M Lee; J-H Kim; H-S Son; E-G Hong; J-M Yu; K-A Han; K-W Min; S-A Chang
Journal:  J Int Med Res       Date:  2010 Jan-Feb       Impact factor: 1.671

Review 3.  Role of adipocytokines in predicting the development of diabetes and its late complications.

Authors:  Nese Ersoz Gulcelik; Aydan Usman; Alper Gürlek
Journal:  Endocrine       Date:  2009-09-25       Impact factor: 3.633

4.  Metabolic syndrome is related to nonalcoholic steatohepatitis in severely obese subjects.

Authors:  Hsien-Liang Huang; Wen-Yuan Lin; Long-Teng Lee; Hsih-Hsi Wang; Wei-Jei Lee; Kuo-Chin Huang
Journal:  Obes Surg       Date:  2007-11       Impact factor: 4.129

5.  Hypoadiponectinemia is associated with impaired glucose tolerance and coronary artery disease in non-diabetic men.

Authors:  Fumiyuki Otsuka; Seigo Sugiyama; Sunao Kojima; Hidetomo Maruyoshi; Tohru Funahashi; Tomohiro Sakamoto; Michihiro Yoshimura; Kazuo Kimura; Satoshi Umemura; Hisao Ogawa
Journal:  Circ J       Date:  2007-11       Impact factor: 2.993

6.  Hypoadiponectinemia and its association with liver fibrosis in morbidly obese patients.

Authors:  Leyla Nazal; Arnoldo Riquelme; Nancy Solís; Margarita Pizarro; Alex Escalona; Mauricio Burotto; Juan Ignacio Méndez; Catalina Saint-Jean; María José Concha; Stefano Giovanni; Diego Awruch; Arturo Morales; Rene Baudrand; Gonzalo Carrasco; María Angélica Domínguez; Oslando Padilla; Manuel Espinoza; Juan Francisco Miquel; Flavio Nervi; Marco Arrese
Journal:  Obes Surg       Date:  2010-01-12       Impact factor: 4.129

7.  Abnormal glucose tolerance in young male patients with nonalcoholic fatty liver disease.

Authors:  Jung Won Yun; Yong Kyun Cho; Jung Ho Park; Hong Joo Kim; Dong Il Park; Chong Il Sohn; Woo Kyu Jeon; Byung Ik Kim
Journal:  Liver Int       Date:  2009-04       Impact factor: 5.828
  7 in total
  1 in total

1.  Adiponectin action: a combination of endocrine and autocrine/paracrine effects.

Authors:  Keith Dadson; Ying Liu; Gary Sweeney
Journal:  Front Endocrinol (Lausanne)       Date:  2011-11-08       Impact factor: 5.555
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.